INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2006

Three patients with advanced cancers experienced unexpectedly long survival times following high-dose intravenous vitamin C therapy.

Clinical details of three well-documented cases of advanced cancer were examined in accordance with National Cancer Institute (NCI) Best Case Series guidelines, with tumour pathology verified by NCI pathologists. Patients had unexpectedly long survival times after receiving high-dose intravenous vitamin C therapy. The authors note that intravenous administration can achieve plasma concentrations capable of in vitro toxicity to cancer cells, warranting a reassessment of intravenous vitamin C in cancer treatment.

Shows an association, not proof of cause and effect.

Study type
Case series
Who was studied
3 patients with advanced cancer confirmed by histopathologic review
What was measured
Survival time and clinical response following high-dose intravenous vitamin C

THE PAPER

Intravenously administered vitamin C as cancer therapy: three cases.

Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M. CMAJ, 2006.

PubMed 16567755 ↗DOI 10.1503/cmaj.050346 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.